Clinical trials
Completed Phase 4 Multiple Sclerosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
103 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 6 |
| 2004 | 5 |
| 2005 | 2 |
| 2006 | 5 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 8 |
| 2012 | 8 |
| 2013 | 13 |
| 2014 | 7 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 103 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 16 |
| Novartis Pharmaceuticals | 13 |
| Merck KGaA, Darmstadt, Germany | 4 |
| Bayer | 3 |
| Brown, Theodore R., M.D., MPH | 3 |
| Hoffmann-La Roche | 3 |
| Sanofi | 3 |
| Teva Neuroscience, Inc. | 3 |
| Germans Trias i Pujol Hospital | 2 |
| Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 103 |
| Multiple Sclerosis, Relapsing-Remitting | 18 |
| Fatigue | 4 |
| Recurrence | 3 |
| Muscle Spasticity | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Anxiety Disorders | 1 |
| Cerebellar Diseases | 1 |
| Constipation | 1 |
| Demyelinating Diseases | 1 |
Trials
Showing 1 to 25 of 103. Each trial links to its page on Pharma Observatory.
3 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.